AI assistant
Snap-on Inc — Director's Dealing 2025
Feb 21, 2025
30335_dirs_2025-02-21_c3eeb0bd-93c4-4184-8cba-0e7933dc5735.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Snap-on Inc (SNA)
CIK: 0000091440
Period of Report: 2025-02-20
Reporting Person: Pagliari Aldo John (Sr VP - Finance & CFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-02-20 | Common Stock | M | 10000 | $138.03 | Acquired | 113956.4161 | Direct |
| 2025-02-20 | Common Stock | S | 2208 | $337.7911 | Disposed | 111748.4161 | Direct |
| 2025-02-20 | Common Stock | S | 2252 | $338.5542 | Disposed | 109496.4161 | Direct |
| 2025-02-20 | Common Stock | S | 436 | $339.6442 | Disposed | 109060.4161 | Direct |
| 2025-02-20 | Common Stock | S | 1410 | $340.6767 | Disposed | 107650.4161 | Direct |
| 2025-02-20 | Common Stock | S | 554 | $341.5123 | Disposed | 107096.4161 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-02-20 | Stock Option (Right to Buy) | $138.03 | M | 10000 | Disposed | 2026-02-11 | Common Stock (10000) | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $168.70 | 2027-02-09 | Common Stock (36000) | 36000 | Direct |
| Stock Option (Right to Buy) | $161.18 | 2028-02-15 | Common Stock (26052) | 26052 | Direct |
| Stock Option (Right to Buy) | $155.92 | 2029-02-14 | Common Stock (23500) | 23500 | Direct |
| Stock Option (Right to Buy) | $155.34 | 2030-02-13 | Common Stock (23500) | 23500 | Direct |
| Stock Option (Right to Buy) | $189.89 | 2031-02-11 | Common Stock (14986) | 14986 | Direct |
| Stock Option (Right to Buy) | $211.67 | 2032-02-10 | Common Stock (11252) | 11252 | Direct |
| Stock Option (Right to Buy) | $249.26 | 2033-02-09 | Common Stock (7850) | 7850 | Direct |
| Stock Option (Right to Buy) | $269.00 | 2034-02-15 | Common Stock (7106) | 7106 | Direct |
| Stock Option (Right to Buy) | $339.73 | 2035-02-13 | Common Stock (5342) | 5342 | Direct |
| Restricted Stock Units | $ | 2026-02-09 | Common Stock (1793) | 1793 | Direct |
| Restricted Stock Units | $ | 2027-02-15 | Common Stock (1533) | 1533 | Direct |
| Restricted Stock Units | $ | 2028-02-13 | Common Stock (1249) | 1249 | Direct |
| Performance Units | $ | Common Stock (3586) | 3586 | Direct | |
| Performance Units | $ | Common Stock (3065) | 3065 | Direct | |
| Performance Units | $ | Common Stock (2498) | 2498 | Direct |
Footnotes
F1: The option was exercised, and a portion of the underlying shares were sold to cover the exercise price and estimated tax liability, pursuant to a Rule 10b5-1 Plan, which was adopted on October 22, 2024.
F2: This transaction was executed in multiple trades at prices ranging from $337.16 to $338.13. The price reported above reflects the weighted average sale price. the reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated.
F3: This transaction was executed in multiple trades at prices ranging from $338.16 to $339.14. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated.
F4: This transaction was executed in multiple trades at prices ranging from $339.19 to $340.15. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated.
F5: This transaction was executed in multiple trades at prices ranging from $340.24 to $341.15. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated.
F6: This transaction was executed in multiple trades at prices ranging from $341.24 to $341.63. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated.
F7: Option fully vested.
F8: Exercise of Rule 16b-3 stock option pursuant to a Rule 10b5-1 Plan, which was adopted on October 22, 2024.
F9: Original stock option grant vests in three annual installments beginning on the date listed in the "Date Exercisable" column.
F10: 1 for 1.
F11: The restricted stock units vest three years from the grant date on the date listed above, assuming continued employment.
F12: If the Company achieves certain goals over the 2023-2025 period, the performance units will vest and stock will be awarded. The target number of units that may be earned is reported above; the maximum amount is 200% of the number reported, subject to plan limits.
F13: If the Company achieves certain goals over the 2024-2026 period, the performance units will vest and stock will be awarded. The target number of units that may be earned is reported above; the maximum amount is 200% of the number reported, subject to plan limits.
F14: If the Company achieves certain goals over the 2025-2027 period, the performance units will vest and stock will be awarded. The target number of units that may be earned is reported above; the maximum amount is 200% of the number reported, subject to plan limits.